Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis

Alimzhan Muxunov; Joseph Almazan; Dina Kalinina; Zhanat Kuanshaliyeva; Abduzhappar Gaipov; Dinara Makhadiyeva; Aida Kabibulatova; Meruyert Madikenova; Altay Nabiyev; Antonio Sarria-Santamera

doi:10.1007/s11136-025-04154-z

journal article Open Access Jan 09, 2026

Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis

Alimzhan Muxunov

Joseph Almazan Dina Kalinina Zhanat Kuanshaliyeva Abduzhappar Gaipov

Dinara Makhadiyeva Aida Kabibulatova Meruyert Madikenova Altay Nabiyev Antonio Sarria-Santamera

Quality of Life Research Vol. 35 No. 2 · Springer Science and Business Media LLC

View at Publisher Save 10.1007/s11136-025-04154-z

Topics

No keywords indexed for this article. Browse by subject →

References

159

[1]

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Boris Bikbov, Caroline A Purcell, Andrew S Levey et al.

The Lancet 2020 10.1016/s0140-6736(20)30045-3

[2]

Noels, H., & Jankowski, J. (2023). Increased risk of cardiovascular complications in chronic kidney disease: Introduction to a compendium. Circulation Research, 132(8), 899–901. https://doi.org/10.1161/CIRCRESAHA.123.322806 10.1161/circresaha.123.322806

[3]

Jha, V., Al-Ghamdi, S. M. G., Li, G., Wu, M.-S., Stafylas, P., Retat, L., & Garcia Sanchez, J. J. (2023). Global economic burden associated with chronic kidney disease: A pragmatic review of medical costs for the Inside CKD Research Programme. Advances in Therapy, 40(10), 4405–4420. https://doi.org/10.1007/s12325-023-02608-9 10.1007/s12325-023-02608-9

[4]

Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., International Society of Nephrology. (2024). Chronic kidney disease and the global public health agenda: An international consensus. Nature Reviews Nephrology, 20(7), 473–485. https://doi.org/10.1038/s41581-024-00820-6 10.1038/s41581-024-00820-6

[5]

Kalyesubula, R., Conroy, A. L., Calice-Silva, V., Kumar, V., Onu, U., Batte, A., & Ulasi, I. (2022). Screening for kidney disease in low- and middle-income countries. Seminars in Nephrology, 42(5), Article 151315. https://doi.org/10.1016/j.semnephrol.2023.151315 10.1016/j.semnephrol.2023.151315

[6]

A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

Kitty J. Jager, Csaba Kovesdy, Robyn Langham et al.

Kidney International 2019 10.1016/j.kint.2019.07.012

[7]

Liyanage, T., Ninomiya, T., Jha, V., Neal, B., Patrice, H. M., Okpechi, I., & Perkovic, V. (2015). Worldwide access to treatment for end-stage kidney disease: A systematic review. Lancet, 385(9981), 1975–1982. https://doi.org/10.1016/S0140-6736(14)61601-9 10.1016/s0140-6736(14)61601-9

[8]

Stanifer, J. W., Muiru, A., Jafar, T. H., & Patel, U. D. (2016). Chronic kidney disease in low- and middle-income countries. Nephrology, Dialysis, Transplantation, 31(6), 868–874. https://doi.org/10.1093/ndt/gfv466 10.1093/ndt/gfv466

[9]

Hussien, H., Apetrii, M., & Covic, A. (2021). Health-related quality of life in patients with chronic kidney disease. Expert Review of Pharmacoeconomics & Outcomes Research, 21(1), 43–54. https://doi.org/10.1080/14737167.2021.1854091 10.1080/14737167.2021.1854091

[10]

Valderrábano, F., Jofre, R., & López-Gómez, J. M. (2001). Quality of life in end-stage renal disease patients. American Journal of Kidney Diseases, 38(3), 443–464. https://doi.org/10.1053/ajkd.2001.26824 10.1053/ajkd.2001.26824

[11]

Cooper, J. T., Lloyd, A., Sanchez, J. J. G., Sörstadius, E., Briggs, A., & McFarlane, P. (2020). Health related quality of life utility weights for economic evaluation through different stages of chronic kidney disease: A systematic literature review. Health and Quality of Life Outcomes, 18(1), 310. https://doi.org/10.1186/s12955-020-01559-x 10.1186/s12955-020-01559-x

[12]

Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis

Benjamin R. Fletcher, Sarah Damery, Olalekan Lee Aiyegbusi et al.

PLoS Medicine 2022 10.1371/journal.pmed.1003954

[13]

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J Page, Joanne E McKenzie, Patrick M Bossuyt et al.

BMJ 2021 10.1136/bmj.n71

[14]

Laucis, N. C., Hays, R. D., & Bhattacharyya, T. (2015). Scoring the SF-36 in orthopaedics: A brief guide. Journal of Bone and Joint Surgery, 97(19), 1628–1634. https://doi.org/10.2106/JBJS.O.00030 10.2106/jbjs.o.00030

[15]

Development of the Kidney Disease Quality of Life (KDQOLTM) Instrument

R. D. Hays, J. D. Kallich, D. L. Mapes et al.

Quality of Life Research 1994 10.1007/bf00451725

[16]

Kidney Disease Quality of Life Instrument (KDQOL). (n.d.). Retrieved October 29, 2025, from https://www.rand.org/health/surveys/kdqol.html.

[17]

World Health Organization. (1998). WHOQOL User Manual. Programme on Mental Health.

[18]

Barker, T. H., Hasanoff, S., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., & Munn, Z. (2025). The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies. JBI Evidence Synthesis. https://doi.org/10.11124/jbies-24-00523 10.11124/jbies-24-00523

[19]

Barker, T. H., Hasanoff, S., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., & Munn, Z. (2025). The revised JBI critical appraisal tool for the assessment of risk of bias for cohort studies. JBI Evidence Synthesis, 23(3), 441–453. https://doi.org/10.11124/jbies-24-00103 10.11124/jbies-24-00103

[20]

Barker, T. H., Habibi, N., Aromataris, E., Stone, J. C., Leonardi-Bee, J., Sears, K., & Munn, Z. (2024). The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evidence Synthesis, 22(3), 378–388. https://doi.org/10.11124/jbies-23-00268 10.11124/jbies-23-00268

[21]

The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials

Timothy Hugh Barker, Jennifer C. Stone, Kim Sears et al.

JBI Evidence Synthesis 2023 10.11124/jbies-22-00430

[22]

Measuring inconsistency in meta-analyses

Julian P T Higgins, Simon G Thompson, Jonathan J Deeks et al.

BMJ 2003 10.1136/bmj.327.7414.557

[23]

Kontopantelis, E., & Reeves, D. (2012). Performance of statistical methods for meta-analysis when true study effects are non-normally distributed: A simulation study. Statistical Methods in Medical Research, 21(4), 409–426. https://doi.org/10.1177/0962280210392008 10.1177/0962280210392008

[24]

Thompson, S. G., & Higgins, J. P. T. (2002). How should meta-regression analyses be undertaken and interpreted? Statistics in Medicine, 21(11), 1559–1573. https://doi.org/10.1002/sim.1187 10.1002/sim.1187

[25]

Bias in meta-analysis detected by a simple, graphical test

Matthias Egger, George Davey Smith, Martin Schneider et al.

BMJ 1997 10.1136/bmj.315.7109.629

[26]

Nayana, S. A., Balasubramanian, T., Nathaliya, P. M., Nimsha Hussain, P., Mohammed Salim, K. T., & Muhammed Lubab, P. (2017). A cross sectional study on assessment of health related quality of life among end stage renal disease patients undergoing hemodialysis. Clinical Epidemiology and Global Health, 5(3), 148–153. https://doi.org/10.1016/j.cegh.2016.08.005 10.1016/j.cegh.2016.08.005

[27]

Sangle, D., Mhatre, H., Mhase, A., Mahadik, V., Attarde, I., Naik, A., & Awale, P. (n.d.). A Cross sectional study to Assess Quality of Life (QOL) in Haemodialysis Patients. National Journal of Integrated Research in Medicine, 4(5).

[28]

Bipin Kumar, S., Karthikeyan, B., Nair, S., Ramasamy, A., Khan, S., & Periasamy, S. (2021). A study of factors affecting dialysis recovery time in haemodialysis patients in India. Indian Journal of Nephrology, 31(5), 460–466. https://doi.org/10.4103/ijn.IJN_241_20 10.4103/ijn.ijn_241_20

[29]

Chauhan, R., & Mendonca, S. (2015). Adequacy of twice weekly hemodialysis in end stage renal disease patients at a tertiary care dialysis centre. Indian Journal of Nephrology, 25(6), 329–333. https://doi.org/10.4103/0971-4065.151762 10.4103/0971-4065.151762

[30]

Yapa, H. E., Purtell, L., Chambers, S., & Bonner, A. (2021). Alterations in symptoms and health-related quality of life as kidney function deteriorates: A cross-sectional study. Journal of Clinical Nursing, 30(11–12), 1787–1796. https://doi.org/10.1111/jocn.15738 10.1111/jocn.15738

[31]

Sathvik, B., Parthasarathi, G., Narahari, M., & Gurudev, K. (2008). An assessment of the quality of life in hemodialysis patients using the WHOQOL-BREF questionnaire. Indian Journal of Nephrology, 18(4), 141. https://doi.org/10.4103/0971-4065.45288 10.4103/0971-4065.45288

[32]

Manavalan, M., Majumdar, A., Harichandra Kumar, K. T., & Priyamvada, P. S. (2017). Assessment of health-related quality of life and its determinants in patients with chronic kidney disease. Indian Journal of Nephrology, 27(1), 37–43. https://doi.org/10.4103/0971-4065.179205 10.4103/0971-4065.179205

[33]

Okoro, R. N. (2021). Cushioning the economic burden of chronic kidney disease for patients in LMICs: The heightened need for a government-driven financial support policy. Health Policy and Technology, 10(2), Article 100507. https://doi.org/10.1016/j.hlpt.2021.100507 10.1016/j.hlpt.2021.100507

[34]

Sharma, S., Kalra, D., Rashid, I., Mehta, S., Maity, M. K., Wazir, K., & Anwar, S. (2023). Assessment of health-related quality of life in chronic kidney disease patients: A hospital-based cross-sectional study. Medicina (Kaunas, Lithuania), 59(10), 1788. https://doi.org/10.3390/medicina59101788 10.3390/medicina59101788

[35]

Abdelghany, M., Elgohary, E., & E. (2016). Assessment of health-related quality of life in patients receiving regular hemodialysis. Journal of Nephrology & Therapeutics. https://doi.org/10.4172/2161-0959.1000246 10.4172/2161-0959.1000246

[36]

Ademola, B. L., Obiagwu, P. N., & Aliyu, A. (2020). Assessment of health-related quality of life of chronic kidney disease patients in Aminu Kano teaching hospital, Kano. Nigerian Journal of Clinical Practice, 23(7), 906–911. https://doi.org/10.4103/njcp.njcp_589_19 10.4103/njcp.njcp_589_19

[37]

Butt, M., Ong, S., Butt, F., Sajjad, A., Rasool, M., Imran, I., & Babar, Z.-U.-D. (2022). Assessment of health-related quality of life, medication adherence, and prevalence of depression in kidney failure patients. International Journal of Environmental Research and Public Health, 19(22), 15266. https://doi.org/10.3390/ijerph192215266 10.3390/ijerph192215266

[38]

Asghar, M., Ahsan, M., Mal, P., Tahir, M., Yasmin, F., & Ahmed, K. (2022). Assessment of quality of life determinants in hemodialysis patients of a developing country: A cross-sectional study during ongoing COVID-19 pandemic. Medicine. https://doi.org/10.1097/MD.0000000000029305 10.1097/md.0000000000029305

[39]

Murali, R., Sathyanarayana, D., & Muthusethupathy, M. (2015). Assessment of quality of life in chronic kidney disease patients using the kidney disease quality of life-short formtm questionnaire in Indian population: A community based study. Asian Journal of Pharmaceutical and Clinical Research, 8(1), 271–274.

[40]

Kuriokose, A., Kenchaappa, V., Hiremath, S., & Varghese, B. (2012). Assessment of quality of life in chronic renal failure patients in India in chronic renal failure patients in India. Quality Issues and Insights in the 21st Century, 1, 20–28.

[41]

Syed, S. A., Cheema, A., Abdullah, M., Chaudhry, M., Malik, A., & Baig, Z. F. (2023). Assessment of quality of life in haemodialysis patients using the World Health Organization quality of life brief version (WHOQOL-BREF) questionnaire. Pakistan Armed Forces Medical Journal, 73, S234–S238. https://doi.org/10.51253/pafmj.v73iSUPPL-1.4825 10.51253/pafmj.v73isuppl-1.4825

[42]

Shrestha, S., Ghotekar, L. R., Sharma, S. K., Shangwa, P. M., & Karki, P. (2008). Assessment of quality of life in patients of end stage renal disease on different modalities of treatment. JNMA; Journal of the Nepal Medical Association, 47(169), 1–6.

[43]

Joshi, U., Subedi, R., Poudel, P., Ghimire, P. R., Panta, S., & Sigdel, M. R. (2017). Assessment of quality of life in patients undergoing hemodialysis using WHOQOL-BREF questionnaire: A multicenter study. International Journal of Nephrology and Renovascular Disease, 10, 195–203. https://doi.org/10.2147/IJNRD.S136522 10.2147/ijnrd.s136522

[44]

Alam, M. B., Khatoon, F., Begum, S. A., Alam, M. M., Faraji, A. H., Mahmud, M. A., & Mekhola, M. H. (2019). Assessment of quality of life of chronic kidney disease patients receiving hemodialysis with kidney disease quality of life TM-36 scale. Mymensingh Medical Journal : MMJ, 28(4), 906–913.

[45]

Joshi, S. A., Almeida, N., & Almeida, A. (2013). Assessment of the perceived quality of life of successful kidney transplant recipients and their donors pre- and post-transplantation. Transplantation Proceedings, 45(4), 1435–1437. https://doi.org/10.1016/j.transproceed.2013.01.037 10.1016/j.transproceed.2013.01.037

[46]

Doan, K. V. D., Nguyen, H. T. M., Nguyen, N. T. H., Dang, K. C., Yang, S.-H., & Duong, T. V. (2020). Associations of socio-demographic, clinical and biochemical parameters with healthcare cost, health- and renal-related quality of life in hemodialysis patients: A clinical observational study. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph17186552 10.3390/ijerph17186552

[47]

Boukhira, I., Jidane, S., & Belyamani, L. (2022). Associations of socio-demographic, clinical, and biochemical parameters with quality of life among hemodialysis patients in Morocco. Middle East Journal of Rehabilitation and Health Studies. https://doi.org/10.5812/mejrh-122559 10.5812/mejrh-122559

[48]

Nguyen, T.-H., Mohd, R., Daud, Z. ’M., Talib, R. A., & Poh, B.-K. (2024). Changes in the quality of life and nutrition markers in transition from end-stage kidney disease to kidney transplantation: Insights from a Vietnamese cohort. Cureus, 16(6), Article e62105. https://doi.org/10.7759/cureus.62105 10.7759/cureus.62105

[49]

Sarker, M., Moriyama, M., Rashid, H., Rahman, M., Chisti, M., Das, S., & Faruque, A. (2022). Chronic kidney disease awareness campaign and mobile health education to improve knowledge, quality of life, and motivation for a healthy lifestyle among patients with chronic kidney disease in Bangladesh: Randomized controlled trial. Journal of Medical Internet Research. https://doi.org/10.2196/37314 10.2196/37314

[50]

Comparison of Depression, Stress, Anxiety, Cognitive Status, and Quality of Life Before and After Renal Transplantation

Sudip S Mukherjee, Suprakash Chaudhury

Cureus 2024 10.7759/cureus.71983

Showing 50 of 159 references

Metrics

1

Citations

159

References

Details

Published: Jan 09, 2026
Vol/Issue: 35(2)
License: View

Authors

Antonio Sarria-Santamera

Funding

Ministry of Education and Science of the Republic of Kazakhstan Award: AP26197503

Cite This Article

Alimzhan Muxunov, Joseph Almazan, Dina Kalinina, et al. (2026). Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis. Quality of Life Research, 35(2). https://doi.org/10.1007/s11136-025-04154-z

Health-related quality of life in chronic kidney disease patients in low- and lower-middle income countries: a systematic review and meta-analysis

You May Also Like